Note

pubs.acs.org/joc

Chiral Gold Phosphate Catalyzed Tandem Hydroamination/
Asymmetric Transfer Hydrogenation Enables Access to Chiral
Tetrahydroquinolines
Yu-Liu Du, Yue Hu, Yi-Fan Zhu, Xi-Feng Tu, Zhi-Yong Han,* and Liu-Zhu Gong
Hefei National Laboratory for Physical Sciences at the Microscale and Department of Chemistry, University of Science and
Technology of China, Hefei 230026, China
*S Supporting Information

ABSTRACT: A highly eﬃcient chiral gold phosphate-
catalyzed tandem hydroamination/asymmetric transfer hydro-
genation reaction is described. A series of chiral
tetrahy-
droquinolines were obtained in excellent yields and
enantioselectivities. In this reaction, the gold catalyst enables
both the hydroamination step as a π-Lewis acid and the
asymmetric hydrogen-transfer process as an eﬀective chiral
Lewis acid.

prevalent

C hiral 1,2,3,4-tetrahydroquinoline not only represents a

skeleton in numerous naturally occurring
alkaloids and artiﬁcial biorelated molecules but also emerges
as a privileged building block in drug discovery, which has
stimulated a great demand and consequent development of
it.1 Generally, catalytic
asymmetric synthetic methods for
asymmetric hydrogenation of prepared quinolines provides the
most widely used access to chiral tetrahydroquinolines (Scheme
1, eq 1).2 Various group VIII transition metals, such as iridium,3
ruthenium,4 rhodium,5 and palladium,6 incorporated with chiral
ligands, deliver high eﬃciency for
the enantioselective
reduction of quinolines. Rueping and co-workers developed
the ﬁrst organocatalytic asymmetric transfer hydrogenation of
quinolines.7 Recently, we found that chiral gold phosphate is
able to catalyze the asymmetric transfer hydrogenation of
quinolines very eﬃciently.

Despite these achievements, asymmetric hydrogenation of
quinolines inevitably suﬀers from harsh conditions and low
overall step eﬃciency brought by preceding quinoline synthesis.
To overcome this, we and other groups7 have been involved in
step-economical
tetrahydroquinoline syntheses with readily
available materials. From o-aminobenzaldehyde and β-keto
esters, we developed a tandem Friedländer condensation/
asymmetric transfer hydrogenation reaction via Mg(OTf)2/
chiral phosphoric acid relay catalysis.8 Through the combina-
tion of gold catalysis and chiral Brønsted acid catalysis, alkynyl
amines were directly transformed into chiral tetrahydroquino-
lines (eq 2).9 However, this Au/organo relay catalytic process
demands 5 mol % gold catalyst and 15 mol % chiral phosphoric
acid,10
this
metholodgy. Previously, we have found that chiral gold
phosphate could serve as a highly eﬃcient catalyst for the
asymmetric transfer hydrogenation of quinolines,11 with the

lowering the practical applicability of

thus

Scheme 1. Strategy for Enantioselective Synthesis of Chiral
1,2,3,4-Tetrahydroquinolines

stereoselectivity controlled by the chiral counteranion.12,13 We
envisioned that, with an eﬃcient gold catalyst, the tandem
process might be realized through solely gold catalysis.14
Herein, we disclose a high yielding and enantioselective cascade
hydroamination/asymmetric transfer hydrogenation reaction,

Received: February 6, 2015
Published: April 7, 2015

© 2015 American Chemical Society

4754

DOI: 10.1021/acs.joc.5b00153
J. Org. Chem. 2015, 80, 4754−4759

The Journal of Organic Chemistry
Table 1. Evaluation of Catalysts and Optimization of Reaction Conditionsa

Note

entry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

B*−H
4a
4b
4c
4d
4e
4e
4e
4e
4e
4e
4e
4e
4e
4e
4e
4e

[Au] mol %

1
1
1
1
1
1
1
1
1
1
1
1
1
0.5
0.2
0.1

5
5a
5a
5a
5a
5a
5b
5c
5a
5a
5a
5a
5a
5a
5a
5a
5a

solvent
Tol
Tol
Tol
Tol
Tol
Tol
Tol
Tol
Tol
Tol
CH2Cl2
THFg
p-xylene
Tol
Tol
Tol

f

yield (%)

47
57
68
54
80
55
5
74
68
60
<5
trace
59
80
81
59

eeb
9
34
96
15
98
10
98
93c
90d
97e
97

80
98
98
98

aUnless indicated otherwise, the reaction of 1a (0.1 mmol), 2a (R = Et, 0.24 mmol) was carried out in toluene (1.5 mL) at 90 °C for 16 h under Ar
in the presence of a gold catalyst precursor (1 mol %) and Brønsted acid (1 mol %). bThe ee was determined by HPLC. cR = Me. dR = Bn. eR =
Allyl. fReaction was carried out at rt for 32 h. gReaction was carried out at 60 °C.
<para sub="scope">
Under

from electron-deﬁcient

the optimized reaction conditions,

the general
applicability of the reaction toward substituted 2-(2-propynyl)-
aniline derivatives were investigated in the presence of 0.2 mol
% of chiral gold phosphate generated from (IMes)AuMe and
4e (Table 2). The gold catalytic tandem reaction tolerated a
wide range of substrates. For 2-(2-propynyl)anilines bearing
various aromatic substituents,
to
electron-rich, on the propynyl moiety (entries 3a−3f), the
tandem reaction proceeded cleanly to give tetrahedroquinolines
with good yields (from 81% to 86%) and excellent
enantioselectivities (from 96% to 98% ee). An aliphatic
substituent exhibited a passive eﬀect of the enantioselectivity:
n-propyl and n-butyl substituted 2-(2-propynyl)anilines (entries
3g−3h) provided the desired product with good yields yet
lower enantiometric excess values. Long aliphatic chain
substituted aromatic substituents (entry 3i) maintained the
excellent stereoselectivity and even enhanced the yield to 91%.
Moreover, substituents on the aniline moiety (entries 3j−3k)
were also tolerable. Both electron-withdrawing and -donating
substituents were suitable for the reaction, resulting in good
conversion and excellent enantioselectivity.
</para>
catalyzed by as low as 0.2 mol % single chiral gold phosphates
(eq 3).11,15
<para sub=“opt”>
Our initial investigation included the reaction of 2-(3-phenyl-
2-propyl)aniline (1a) with Hantzsch ester (2a) at 90 °C using
chiral gold phosphates generated in situ from 1 mol % of
IMesAuMe and 1 mol % BINOL-based phosphoric acid (4).
Among the chiral phosphoric acids we investigated (Table 1,
entries 1−5), 4e was identiﬁed to be ideal for this process,
which improved the stereochemical outcome to 98% ee with
80% yield. Then, several gold ligands were examined (entries
5−7). Carbene-type ligand IMes provided the best result in
yield and enantioselectivity (entry 5) while PPh3 gave the
product with excellent stereoselectivity but only 5% yield (entry
7), and IPr
ligand led to a moderate yield and poor
enantioselectivity (entry 6). With the results above, an
examination of diﬀerent Hantzsch esters (entries 8−10)
revealed that 2a was the best hydride source. Moreover, a
brief screening of solvents (entries 11−13) resulted in toluene
being optimal
for this reaction regarding both yield and
enantioselectivity. With the optimized conditions in hand, we
tried to lower the catalyst loading (entries 14−16). To our
delight, 0.2 mol % of catalyst still furnished the reaction without
any drop of yield and enantioselectivity. A further decrease in
gold loading to 0.1 mol % led to the retention of
stereoselectivity and, however, a notable reduction of target
product yield.
</para>
Vinyl substituted substrates 1l and 1m were investigated in
the presence of 2 mol % of gold catalyst and 3.0 equiv of the
Hantzsch ester (Scheme 2). Unexpectedly, aliphatic substituted
products 3l and 3m were obtained with moderate yields and
enantioselectivities. Obviously, the substituted vinyl group was

4755

DOI: 10.1021/acs.joc.5b00153
J. Org. Chem. 2015, 80, 4754−4759

The Journal of Organic Chemistry
Table 2. Scope of 2-(2-Propynyl)aniline Derivatives of the Gold-Catalyzed Tandem Reactiona,b

Note

aUnless indicated otherwise, the reaction of 1a (0.1 mmol), 2a (0.24 mmol) was carried out in toluene (1.5 mL) at 90 °C for 16 h under Ar in the
presence of a gold catalyst (0.2 mol %), Brønsted acid (0.2 mol %). bThe ee was determined by HPLC.

Scheme 2. Vinyl Substituted 2-(2-Propynyl)aniline Derivatives of the Gold-Catalyzed Tandem Reaction

Scheme 3. Proposed Mechanism for This Tandem Reaction

reduced as well by a Hantzsch ester under the reaction
conditions.

Interestingly, during the process of this tandem reaction, we
observed the formation of quinoline III, which disappeared at

4756

DOI: 10.1021/acs.joc.5b00153
J. Org. Chem. 2015, 80, 4754−4759

The Journal of Organic Chemistry
<para sub="scope">
the end of the reaction. Based on this, we proposed the reaction
might proceed via the mechanism as shown in Scheme 3. Chiral
gold phosphate formed in situ functions as both a π-Lewis acid
catalyst and a Lewis acid catalyst. In the asymmetric transfer-
hydrogenation step, both Hantzsch ester 2 and 2H-quinoline
intermediate I could participate as the hydrogen source. In the
latter case, quinoline III would be formed and underwent
subsequent asymmetric reduction leading to the desired
product as well.
</para>
In summary, we have developed an eﬀective method for
directly transforming 2-(2-propynyl)aniline derivatives into
optically active tetrahydroquinolines in one operation with
moderate to good yields and excellent enantioselectivities
through the catalysis of only 0.2 mol % of chiral gold phosphate
generated in situ from IMesAuMe and a chiral phosphoric acid.
Notably in this reaction, the gold catalyst enables both the
intramolecular hydroamination as a π-Lewis acid and the
asymmetric reduction as a highly eﬀective chiral Lewis acid.
■ EXPERIMENTAL SECTION
<para sub=“exp”>
General Method. NMR spectra were recorded on a 400 MHz
spectrometer. HRMS spectra were recorded on a TOF-Q mass
spectrometer. The enantiomeric excess of
the compounds was
determined by chiral HPLC using racemic compounds as references.
All starting materials, reagents, and solvents were purchased from
commercial suppliers and used as supplied unless otherwise stated.
Toluene and THF were dried over Na and distilled prior to use.
MeCN and CH2Cl2 were dried over CaH2 and distilled prior to use.
Chloroform was washed by water and dried over Na2SO4. 2-(2-
Propynyl)aniline derivatives 1 were synthesized according to the
reported procedure.9 The absolute conﬁguration of 1,2,3,4-tetrahy-
droquinoline derivatives were determined by comparison of HPLC
retention time with that reported in the literature.7a,9,11

General Procedures for the Synthesis of 1,2,3,4-Tetrahydro-
quinoline Derivatives. A mixture of IMesAuMe (0.2 mol %) and
phosphoric acid 4e (0.2 mol %), Hantzsch dihydropyridine 2a (0.24
mmol, 2.4 equiv), and 2-(2-propynyl)aniline derivatives 1 (0.1 mmol)
were ﬂushed with argon and suspended in toluene (1.5 mL) in a
screw-capped vial. The resulting mixture was allowed to stir at 90 °C
for 16 h. The solvent was removed under reduced pressure and then
puriﬁed through column chromatography on silica gel (ethyl acetate/
petroleum ether = 20:1) to aﬀord the product.

2-(3-Phenylprop-2-ynyl)aniline (1a). 1H NMR (CDCl3, 400 MHz)
δ (ppm) 3.66 (s, 2H), 3.76 (brs, 2H), 6.70 (d, J = 7.6 Hz, 1H), 6.78 (t,
J = 7.2 Hz, 1H), 7.11 (t, J = 7.6 Hz, 1H), 7.22−7.29 (m, 4H),7.40−
7.43 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ (ppm) 22.5, 82.8, 86.2,
116.0, 118.9, 121.4, 123.4, 127.9, 128.0, 128.2, 129.4, 131.6, 144.5.

2-(3-p-Tolylprop-2-ynyl)aniline (1b). 1H NMR (CDCl3, 400 MHz)
δ (ppm) 2.33 (s, 3H), 3.66 (s, 2H), 3.91 (brs, 2H), 6.71 (d, J = 7.88
Hz, 1H), 6.77(t, J = 7.2 Hz, 1H), 7.08−7.13(m, 3H), 7.23−7.25 (m,
1H), 7.30 (d, J = 8.0 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δ (ppm)
21.4, 22.7, 82.9, 85.4, 116.0, 118.9, 120.3, 121.6, 128.0, 129.0, 129.5,
131.5, 138.0, 144.6.

2-(3-m-Tolylprop-2-ynyl)aniline (1c).

1H NMR (CDCl3, 400
MHz) δ (ppm) 2.31 (s, 3H), 3.66 (s, 2H), 3.86 (brs, 2H), 6.71 (d,
J = 7.6 Hz, 1H), 6.78 (t, J = 7.6 Hz, 1H), 7.11 (td, J = 8.0, 1.6 Hz, 2H),
7.17 (t, J = 7.6 Hz, 1H), 7.22−7.25 (m, 3H); 13C NMR (CDCl3, 100
MHz) δ (ppm) 21.2, 22.7, 83.0, 85.8, 116.1, 118.9, 121.5, 123.2, 128.1,
128.7, 128.8, 128.9, 129.5, 132.3, 137.9, 144.6.

2-(3-(4-Chlorophenyl)prop-2-yn-1-yl)aniline (1d).

1H NMR
(CDCl3, 400 MHz) δ (ppm) 3.66 (s, 2H), 3.84 (brs, 2H), 6.72 (d,
J = 7.9 Hz, 1H), 6.78 (t, J = 7.5 Hz, 1H), 7.11 (td, J = 7.7, 1.4 Hz, 2H),
7.22−7.27 (m, 3H), 7.32−7.35 (m, 2H); 13C NMR (CDCl3, 100
MHz) δ (ppm) 22.6, 81.8, 87.3, 116.0, 119.0, 121.1, 121.9, 128.2,
128.6, 128.8, 128.9, 129.4, 132.9, 134.0, 144.5; HR-ESI calculated for
C15H12ClN [M + H]: 242.0737, found: 242.0760. Mp 72−75 °C.
2-(3-(4-Bromophenyl)prop-2-ynyl)aniline (1e). 1H NMR (CDCl3,
400 MHz) δ (ppm) 3.64 (s, 2H), 3.86 (brs, 2H), 6.72 (dd, J = 7.6, 0.8

Note

Hz, 1H), 6.78 (td, J = 7.2, 1.2 Hz, 1H), 7.11 (td, J = 7.6, 1.2 Hz, 1H),
7.22−7.28 (m, 3H), 7.40−7.42 (m, 2H); 13C NMR (CDCl3, 100
MHz) δ (ppm) 22.6, 81.8, 87.5, 116.0, 118.9, 121.0, 122.1, 122.4,
128.1, 129.5, 131.5, 133.1, 144.5. Mp 72−77 °C.

2-(3-(4-Fluorophenyl)prop-2-ynyl)aniline (1f). 1H NMR (CDCl3,
400 MHz) δ (ppm) 3.64 (s, 2H), 3.80 (brs, 2H), 6.71 (d, J = 8.0 Hz,
1H), 6.78 (td, J = 7.4, 1.0 Hz, 1H), 6.97 (tt, J = 8.7, 1.8 Hz, 2H), 7.11
(td, J = 7.7, 1.3 Hz, 1H), 7.23−7.25 (m, 1H), 7.36−7.41 (m, 2H); 13C
NMR (CDCl3, 100 MHz) δ (ppm) 22.5, 81.7, 85.8, 115.3, 115.5,
115.9, 118.9, 121.2, 128.0, 129.4, 133.4, 133.5, 144.5, 161.0, 163.5.
2-(Hept-2-yn-1-yl)aniline (1g). 1H NMR (CDCl3, 400 MHz) δ
(ppm) 0.90 (t, J = 7.2 Hz, 3H), 1.35−1.52 (m, 4H), 2.10 (tt, J = 6.8,
2.4 Hz, 2H), 3.41 (t, J = 2.4 Hz, 2H), 3.88 (brs, 2H), 6.69 (dd, J = 8.0,
1.2 Hz, 1H), 6.74 (td, J = 7.6, 1.2 Hz, 1H), 7.08 (td, J = 7.6, 1.2 Hz,
1H), 7.16 (d, J = 7.6 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ (ppm)
13.6, 18.5, 22.0, 22.1, 31.0, 76.2, 82.9, 115.8, 118.8, 122.3, 127.8, 129.3,
144.6.

2-(Hex-2-yn-1-yl)aniline (1h). 1H NMR (CDCl3, 400 MHz) δ
(ppm) 0.97 (t, J = 7.36 Hz, 3H), 1.52 (dd, J = 14.5, 7.2 Hz, 2H), 2.16
(tt, J = 7.1, 2.4 Hz, 2H), 3.41 (t, J = 2.4 Hz, 2H), 3.88 (brs, 2H), 6.69
(dd, J = 7.9, 1.1 Hz, 1H), 6.74 (td, J = 7.4, 1.2 Hz, 1H), 7.08 (td, J =
7.8, 1.5 Hz, 1H), 7.17 (t, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 100
MHz) δ (ppm) 13.6, 20.8, 22.1, 22.4, 76.4, 82.8, 115.9, 118.8, 122.3,
127.8, 129.3, 144.6; HR-ESI calculated for C12H15N [M + H]:
174.1283, found: 174.1293.

2-(3-(4-Pentylphenyl)prop-2-yn-1-yl)aniline (1i).

1H NMR
(CDCl3, 400 MHz) δ (ppm) 0.88 (t, J = 6.93 Hz, 3H), 1.31 (m,
4H), 1.59 (m, 2H), 2.59 (dd, J = 14.4, 6.8 Hz, 2H), 3.61 (s, 1H), 3.89
(brs, 2H), 6.59 (d, J = 8.4 Hz, 2H), 7.10 (m, 3H), 7.19 (dd, J = 8.4, 2.3
Hz, 1H), 7.31(dd, J = 9.8, 8.1 Hz, 2H), 7.36 (d, J = 2.3 Hz, 1H); 13C
NMR (CDCl3, 100 MHz) δ (ppm) 22.3, 82.7, 86.4, 98.5, 100.7, 109.4,
113.7, 123.4, 128.0, 128.2, 131.6, 138.9, 140.6, 147.1; HR-ESI
calculated for C20H23N [M + H]: 278.1909, found: 278.1913.

5-Chloro-2-(3-phenylprop-2-yn-1-yl)aniline (1j).

1H NMR
(CDCl3, 400 MHz) δ (ppm) 3.60 (s, 2H), 3.93 (brs, 2H), 6.69 (d,
J = 2.0 Hz, 1H) 6.73 (dd, J = 8.0, 2.0 Hz, 1H), 7.15 (d, J = 8.0 Hz,
1H), 7.27−7.30 (m, 3H), 7.38−7.43 (m, 2H); 13C NMR (CDCl3, 100
MHz) δ (ppm) 22.1, 88.2, 85.5, 115.5, 118.6, 119.7, 123.2, 128.1,
128.3, 130.4, 131.6, 133.4, 145.7.

6-(3-Phenylprop-2-yn-1-yl)benzo[d][1,3]dioxol-5-amine (1k). 1H
NMR (CDCl3, 400 MHz) δ (ppm) 3.58 (s, 2H), 3.67 (brs, 2H), 5.86
(s, 2H), 6.32 (s, 1H), 6.80 (s, 1H), 7.27−7.33 (m, 3H), 7.38−7.45 (m,
2H); 13C NMR (CDCl3, 100 MHz) δ (ppm) 22.3, 82.7, 86.4, 98.5,
100.7, 109.4, 113.7, 123.4, 128.0, 128.2, 131.6, 138.9, 140.6, 147.1.
2-(Pent-4-en-2-yn-1-yl)aniline (1l). 1H NMR (400 MHz, CDCl3) δ
7.17 (d, J = 7.4 Hz, 1H), 7.12−7.05 (m, 1H), 6.76 (t, J = 7.4 Hz, 1H),
6.69 (d, J = 7.9 Hz, 1H), 5.85−5.74 (m, 1H), 5.59 (dd, J = 17.5, 1.8
Hz, 1H), 5.42 (dd, J = 11.0, 2.0 Hz, 1H), 3.82 (brs, 2H), 3.55 (s, 2H).
13C NMR (101 MHz, CDCl3) δ 144.5, 129.4, 128.1, 126.5, 121.3,
118.9, 117.2, 116.0, 86.9, 81.5, 22.5. HR-ESI calculated for C11H11N
[M + H]: 158.0970, found: 158.0963.
(E)-2-(5-Phenylpent-4-en-2-yn-1-yl)aniline (1m). 1H NMR (400
MHz, CDCl3) δ 7.36−7.23 (m, 1H), 7.21−7.16 (m, 1H), 7.13−7.05
(m, 1H), 6.90 (d, J = 16.3 Hz, 1H), 6.81−6.72 (m, 1H), 6.69 (d, J =
7.9 Hz, 1H), 6.15 (ddd, J = 16.2, 4.8, 2.6 Hz, 1H), 3.84 (brs, 2H), 3.60
(s, 2H). 13C NMR (101 MHz, CDCl3) δ 144.6, 141.0, 136.4, 129.5,
128.7, 128.5, 128.1, 126.2, 121.5, 119.0, 116.1, 108.3, 88.6, 82.0, 22.9.
HR-ESI calculated for C17H15N [M + H]: 234.1283, found: 234.1274;
mp 61−64 °C.
(S)-2-Phenyl-1,2,3,4-tetrahydroquinoline (3a). Yield: 81%, 16.9
mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 1.96−2.02 (m, 1H),
2.08−2.10 (m, 1H), 2.74 (dt, J = 16.4, 4.8 Hz, 1H), 2.88−2.90 (m,
1H), 4.00 (s, 1H), 4.41 (dd, J = 9.2, 3.2 Hz, 1H), 6.51 (d, J = 7.6 Hz,
1H), 6.64 (td, J = 7.6, 0.8 Hz, 1H), 6.97−6.99 (m, 2H), 7.26−7.39 (m,
5H); 13C NMR (CDCl3, 100 MHz): δ(ppm) 26.3, 30.9, 56.1, 113.9,
117.0, 120.7, 126.4, 126.8, 127.3, 128.5, 129.2, 144.6, 144.7;
Enantiomeric excess: 98%, determined by HPLC (Chiracel-OD-H,
hexane/isopropanol = 95/5, ﬂow rate 1.0 mL/min, T = 30 °C, 254
nm): tR = 10.44 min (major), tR = 13.90 min (minor).
</para>
4757

DOI: 10.1021/acs.joc.5b00153
J. Org. Chem. 2015, 80, 4754−4759

The Journal of Organic Chemistry

Note
<para sub=“exp”>
(S)-2-(p-Tolyl)-1,2,3,4-tetrahydroquinoline (3b). Yield: 86%, 19.1
mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 1.85−1.95 (m, 1H),
1.99−2.06 (m, 1H), 2.28 (s, 3H), 2.66 (dt, J = 16.3, 4.7 Hz, 1H), 2.84
(ddd, J = 16.3, 10.8, 5.5 Hz, 1H), 3.95 (brs, 1H), 4.32 (dd, J = 9.4, 3.2
Hz, 1H), 6.45 (dd, J = 8.4, 1.0 Hz, 1H), 6.56 (td, J = 7.4, 1.0 Hz, 1H),
6.93 (t, J = 7.02 Hz, 2H), 7.08 (d, J = 7.9 Hz, 1H), 7.18−7.21 (m,
3H); 13C NMR (CDCl3, 100 MHz): δ (ppm) 20.1, 25.5, 30.0, 55.0,
112.9, 116.1, 119.9, 125.4, 125.8, 128.2, 128.3, 136.1, 140.8, 143.8;
Enantiomeric excess: 96%, determined by HPLC (Chiracel-OD-H,
hexane/isopropanol = 95/5, ﬂow rate 1.0 mL/min, T = 30 °C, 254
nm): tR = 8.37 min (major), tR = 15.11 min (minor).
(S)-2-(m-Tolyl)-1,2,3,4-tetrahydroquinoline (3c). Yield: 83%, 18.5
mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 1.93−2.03 (m, 1H), 2.10
(ddt, J = 7.6, 5.5, 4.2 Hz, 1H), 2.35 (s, 3H), 2.74 (dt, J = 16.3, 4.6 Hz,
1H), 2.92 (ddd, J = 16.4, 10.9, 5.5 Hz, 1H), 4.01 (brs, 1H), 4.39 (dd, J
= 9.5, 3.3 Hz, 1H), 6.53 (dd, J = 8.4, 1.0 Hz, 1H), 6.64 (td, J = 7.4, 1.1
Hz, 1H), 7.00 (t, J = 7.1 Hz, 2H), 7.09 (d, J = 7.4 Hz, 1H), 7.17−7.25
(m, 3H); 13C NMR (CDCl3, 100 MHz): δ (ppm) 21.5, 26.6, 31.1,
56.3, 114.0, 117.1, 120.9, 123.6, 126.9, 127.3, 128.2, 128.5, 129.3,
138.3, 144.8; Enantiomeric excess: 96%, determined by HPLC
(Chiracel-OD-H, hexane/isopropanol = 95/5, ﬂow rate 1.0 mL/min,
T = 30 °C, 254 nm): tR = 8.43 min (major), tR = 10.90 min (minor).
(S)-2-(4-Chlorophenyl)-1,2,3,4-tetrahydroquinoline (3d). Yield:
82%, 20.0 mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 1.90−1.99
(m, 1H), 2.06−2.12 (m, 1H), 2.71 (dt, J = 16.4, 4.9 Hz, 1H), 2.90
(ddd, J = 16.1, 10.4, 5.4 Hz, 1H), 4.01 (brs, 1H), 4.42 (dd, J = 9.1, 3.3
Hz, 1H), 6.54 (d, J = 7.9 Hz, 1H), 6.67 (dd, J = 7.4, 1.0 Hz, 1H),
6.98−7.03 (m, 2H), 7.29−7.33 (m, 4H), 13C NMR (CDCl3, 100
MHz): δ (ppm) 26.1, 31.0, 55.6, 114.1, 117.4, 120.8, 127.0, 127.9,
20 = −40.9 (c 0.17, CHCl3); HR-
128.7, 129.3, 133.0, 143.4, 144.4; [α]D
ESI calculated for C15H14ClN [M + H]: 244.0893, found: 244.0899;
Enantiomeric excess: 96%, determined by HPLC (Chiracel-OD-H,
hexane/isopropanol = 95/5, ﬂow rate 1.0 mL/min, T = 30 °C, 254
nm): tR = 13.17 min (major), tR = 24.42 min (minor).

(S)-2-(4-Bromophenyl)-1,2,3,4-tetrahydroquinoline (3e). Yield:
85%, 24.5 mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 0.93 (t, J =
6.8 Hz, 3H), 1.33−1.64 (m, 7H), 1.93−1.99 (m, 1H), 2.69−2.85 (m,
2H), 3.20−3.26 (m, 1H), 3.81 (brs, 1H), 6.47 (dd, J = 8.4, 1.0 Hz,
1H), 6.59 (td, J = 7.4, 1.0 Hz, 1H), 6.93−6.97 (m, 2H); 13C NMR
(CDCl3, 100 MHz): δ (ppm) 14.1, 22.8, 26.4, 27.9, 28.1, 36.4, 51.6,
114.0, 116.9, 121.4, 126.7, 129.3, 144.8. Enantiomeric excess: 98%,
determined by HPLC (Chiracel-OD-H, hexane/isopropanol = 95/5,
ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 15.28 min (major), tR
= 28.83 min (minor).
(S)-2-(4-Fluorophenyl)-1,2,3,4-tetrahydroquinoline (3f). Yield:
87%, 19.7 mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 1.91−2.00
(m, 1H), 2.04−2.12 (m, 1H), 2.72 (dt, J = 16.4, 4.8 Hz, 1H), 2.92
(ddd, J = 16.2, 10.6, 5.5 Hz, 1H), 4.02 (brs, 1H), 4.42 (dd, J = 9.3, 3.2
Hz, 1H), 6.54 (d, J = 7.7 Hz, 1H), 6.65 (td, J = 7.4, 1.1 Hz, 1H), 6.99−
7.05 (m, 4H), 7.32−7.37(m, 2H); 13C NMR (CDCl3, 100 MHz): δ
(ppm) 26.3, 31.1, 55.6, 114.1, 115.2, 115.5, 117.4, 120.8, 127.0, 128.0,
128.1, 129.3, 140.5, 144.6, 160.9, 163.4. Enantiomeric excess: 99%,
determined by HPLC (Chiracel-OD-H, hexane/isopropanol = 95/5,
ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 10.95 min (major), tR
= 17.53 min (minor).
(R)-2-Butyl-1,2,3,4-tetrahydroquinoline (3g). Yield: 82%, 15.5 mg;
1H NMR (CDCl3, 400 MHz): δ (ppm) 0.93 (t, J = 7.1 Hz, 3H), 1.33−
1.40 (m, 4H), 1.46−1.52 (m, 2H), 1.55−1.64 (m, 2H), 1.93−1.99 (m,
1H), 2.17 (s, 1H), 2.69−2.85 (m, 2H), 3.20−3.26 (m, 1H), 3.81 (brs,
1H), 6.47 (dd, J = 8.4, 1.0 Hz, 1H), 6.59 (td, J = 7.4, 1.1 Hz, 1H),
6.93−6.97 (m, 2H) ; 13C NMR (CDCl3, 100 MHz): δ (ppm) 14.1,
22.8, 26.4, 27.9, 28.1, 36.4, 51.6, 114.0, 116.9, 121.4, 126.7, 129.3,
144.8. Enantiomeric excess: 43%, determined by HPLC (Chiracel-IC-
H, hexane/isopropanol = 99.7/0.3, ﬂow rate 0.8 mL/min, T = 30 °C,
254 nm): tR = 12.57 min (major), tR = 13.67 min (minor).

(R)-2-Propyl-1,2,3,4-tetrahydroquinoline (3h). Yield: 87%, 15.3
mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 0.96 (t, J = 7.1 Hz, 3H),
1.37−1.51 (m, 4H), 1.51−1.64 (m, 1H), 1.92−1.98 (m,1H), 2.69−
2.85 (m, 2H), 3.25 (dtd, J = 9.4, 6.1, 3.0 Hz, 1H), 3.72 (brs, 1H), 6.46
(dd, J = 8.4, 1.0 Hz, 1H), 6.59 (td, J =7.4, 1.0 Hz, 1H), 6.93−6.96 (m,

2H); 13C NMR (CDCl3, 100 MHz): δ (ppm) 14.2, 18.9, 26.5,28.1,
38.9, 51.3, 114.0, 116.9, 121.4, 126.7, 129.3, 144.8; [α]D
20 = 17.6 (c
0.036, CHCl3); HR-ESI calculated for C12H17N [M + H]: 176.1439,
found: 176.1452; Enantiomeric excess: 61%, determined by HPLC
(Chiracel-IC-H, hexane/isopropanol = 99.7/0.3, ﬂow rate 0.8 mL/
min, T = 30 °C, 254 nm): tR = 16.88 min (major), tR = 18.86 min
(minor).

(S)-2-(4-Pentylphenyl)-1,2,3,4-tetrahydroquinoline (3i). Yield:
91%, 25.4 mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 0.89(t, J =
6.9 Hz, 3H), 1.28−1.36 (m, 4H), 1.61 (dt, J = 9.3, 7.5 Hz, 2H), 1.89−
1.98 (m, 1H), 2.05−2.12 (m, 1H), 2.57−2.61 (m, 2H), 2.69 (dt, J =
14.8, 3.8 Hz, 1H), 2.86 (ddd, J = 16.2, 10.6, 5.4 Hz, 1H), 4.05 (brs,
1H), 4.4 (dd, J = 9.2, 3.3 Hz, 1H), 6.39 (d, J = 8.4 Hz, 1H), 7.05−7.80
(m, 2H), 7.14−7.17 (m, 2H), 7.24−7.26 (m, 3H); 13C NMR (CDCl3,
100 MHz): δ (ppm) 14.0, 22.6, 26.2, 30.4, 31.2, 31.6, 36.0, 55.9, 108.4,
115.3, 122.9, 126.4, 127.4, 128.6, 129.1, 129.5, 131.7, 141.5, 142.4,
20 = −22.78 (c 0.06, CHCl3); HR-ESI calculated for
143.8; [α]D
C20H25N [M + H]: 280.2065, found: 280.2069; Enantiomeric excess:
96%, determined by HPLC (Chiracel-OD-H, hexane/isopropanol =
95/5, ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 6.09 min
(major), tR = 11.08 min (minor).
(S)-7-Chloro-2-phenyl-1,2,3,4-tetrahydroquinoline (3j). Yield:
83%, 20.2 mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 1.89−2.00
(m, 1H), 2.07−2.13 (m, 1H), 2.66 (dt, J = 16.4, 4.8 Hz, 1H), 2.78−
2.86 (m, 1H), 4.10 (brs, 1H), 4.42 (dd, J = 9.2, 3.6 Hz, 1H), 6.50 (d, J
= 2.0 Hz, 1H), 6.58 (dd, J = 8.0, 2.0 Hz, 1H), 6.87 (d, J = 8.0 Hz, 1H),
7.26−7.35 (m, 5H); 13C NMR (CDCl3, 100 MHz): δ (ppm) 25.7,
30.5, 55.9, 113.3, 116.8, 119.2, 126.4, 127.5, 128.6, 130.1, 132.1, 144.3,
145.6; HR-ESI calculated for C20H25N [M + H]: 280.2065, found:
280.2069. Enantiomeric excess: 97%, determined by HPLC (Chiracel-
OD-H, hexane/isopropanol = 95/5, ﬂow rate 1.0 mL/min, T = 30 °C,
254 nm): tR = 12.77 min (major), tR = 22.77 min (minor).
(S)-6-Phenyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]quinoline (3k).
Yield: 70%, 17.8 mg; 1H NMR (CDCl3, 400 MHz): δ (ppm) 1.91−
2.01 (m, 1H), 2.05−2.12 (m, 1H), 2.63 (dt, J = 16.0, 4.8 Hz, 1H),
2.81−2.89 (m, 1H), 3.81 (brs, 1H), 4.34 (dd, J = 9.6, 3.2 Hz, 1H), 5.81
(d, J = 2.4 Hz, 1H), 5.81 (d, J = 2.4 Hz, 1H), 6.14 (s, 1H), 6.50 (s,
1H), 7.24−7.29 (m, 1H), 7.29−7.39 (m, 4H); 13C NMR (CDCl3, 100
MHz): δ (ppm) 26.4, 31.1, 56.4, 96.4, 100.3, 109.0, 112.7, 126.5,
127.4, 128.5, 139.3, 139.6, 144.7, 146.3; Enantiomeric excess: 96%,
determined by HPLC (Chiracel-OD-H, hexane/isopropanol = 95/5,
ﬂow rate 1.0 mL/min, T = 30 °C, 254 nm): tR = 15.66 min (major), tR
= 17.91 min (minor).

(R)-2-Ethyl-1,2,3,4-tetrahydroquinoline (3l). Yield: 41%; 6.6 mg.
1H NMR (400 MHz, CDCl3) δ 6.96 (t, J = 7.1 Hz, 2H), 6.59 (t, J =
7.3 Hz, 1H), 6.48 (d, J = 8.0 Hz, 1H), 3.78 (brs, 1H), 3.23−3.10 (m,
1H), 2.88−2.67 (m, 2H), 2.01−1.93 (m, 1H), 1.66−1.46 (m, 3H),
0.99 (t, J = 7.5 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 144.8, 129.3,
126.7, 121.4, 116.9, 114.0, 53.0, 29.4, 27.6, 26.4, 10.1; [α]D
20 = 81.7 (c
0.04, CHCl3) HR-ESI calculated for C11H15N [M + H]: 162.1283,
found: 162.1277. Enantiomeric excess: 69%, determined by HPLC
(Chiracel-IC-H, hexane/isopropanol = 99.7/0.3, ﬂow rate 0.8 mL/
min, T = 30 °C, 254 nm): tR = 7.93 min (major), tR = 8.56 min
(minor).
(R)-2-Phenethyl-1,2,3,4-tetrahydroquinoline (3m). Yield: 57%;
13.5 mg. 1H NMR (400 MHz, CDCl3) δ 7.33−7.26 (m, 2H), 7.24−
7.17 (m, 3H), 6.96 (t, J = 7.2 Hz, 2H), 6.60 (t, J = 7.3 Hz, 1H), 6.45
(d, J = 8.0 Hz, 1H), 3.77 (brs, 1H), 3.36−3.24 (m, 1H), 2.87−2.67 (m,
4H), 2.00 (ddd, J = 12.8, 7.9, 4.9 Hz, 1H), 1.84 (dt, J = 13.1, 6.7 Hz,
2H), 1.67 (dtd, J = 12.8, 10.3, 5.6 Hz, 1H). 13C NMR (101 MHz,
CDCl3) δ 144.5, 141.9, 129.3, 128.5, 128.4, 126.8, 126.0, 121.3, 117.1,
114.2, 51.1, 38.3, 32.2, 28.0, 26.2; [α]D
20 = 40.4 (c 0.094, CHCl3); HR-
ESI calculated for C17H19N [M + H]: 238.1596, found: 238.1588.
Enantiomeric excess: 42%, determined by HPLC (Chiracel-IC-H,
hexane/isopropanol = 99.7/0.3, ﬂow rate 0.8 mL/min, T = 30 °C, 254
nm): tR = 12.76 min (major), tR = 14.49 min (minor).
</para>
4758

DOI: 10.1021/acs.joc.5b00153
J. Org. Chem. 2015, 80, 4754−4759

The Journal of Organic Chemistry

■ ASSOCIATED CONTENT
*S Supporting Information
Characterization data. This material is available free of charge
via the Internet at http://pubs.acs.org.

■ AUTHOR INFORMATION
Corresponding Author
*E-mail: hanzy2014@ustc.edu.cn.
Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

We are grateful for ﬁnancial support from NSFC (21172207)
and the Fundamental Research Funds
the Central
Universities (WK2060190041).

for

■ REFERENCES

(1) (a) Keay, J. G. In Comprehensive Organic Synthesis; Fleming, B. M.
T., Ed.; Pergamon: Oxford, 1991; p 579. (b) Katritzky, A. R.; Rachwal,
S.; Rachwal, B. Tetrahedron 1996, 52, 15031. (c) Sridharan, V.;
Suryavanshi, P. A.; Menéndez, J. C. Chem. Rev. 2011, 111, 7157.
(d) Barton, D. H.; Nakanishi, K.; Cohn, O. M. Comprehensive Natural
Products Chemistry, Vols. 1−9; Elsevier: Oxford, 1999.
(2) (a) Glorius, F. Org. Biomol. Chem. 2005, 3, 4171. (b) Zhou, Y.-G.
Acc. Chem. Res. 2007, 40, 1357. (c) Wang, D.-S.; Chen, Q.-A.; Lu, S.-
M.; Zhou, Y.-G. Chem. Rev. 2011, 112, 2557.
(3) (a) Wang, W.-B.; Lu, S.-M.; Yang, P.-Y.; Han, X.-W.; Zhou, Y.-G.
J. Am. Chem. Soc. 2003, 125, 10536. (b) Zhao, Y. J.; Wang, Y. Q.;
Zhou, Y. G. Chin. J. Catal. 2005, 26, 737. (c) Li, Z.-W.; Wang, T.-L.;
He, Y.-M.; Wang, Z.-J.; Fan, Q.-H.; Pan, J.; Xu, L.-J. Org. Lett. 2008,
10, 5265.
(4) (a) Yang, Z.; Chen, F.; He, Y.-M.; Yang, N.; Fan, Q.-H. Catal. Sci.
Technol. 2014, 4, 2887. (b) Wang, T.; Zhuo, L.-G.; Li, Z.; Chen, F.;
Ding, Z.; He, Y.; Fan, Q.-H.; Xiang, J.; Yu, Z.-X.; Chan, A. S. C. J. Am.
Chem. Soc. 2011, 133, 9878.
(5) (a) Li, H. Y.; Horn, J.; Campbell, A.; House, D.; Nelson, A.;
Marsden, S. P. Chem. Commun. 2014, 50, 10222. (b) Wang, C.; Li, C.;
Wu, X.; Pettman, A.; Xiao, J. Angew. Chem., Int. Ed. 2009, 48, 6524.
(6) Cai, X.-F.; Huang, W.-X.; Chen, Z.-P.; Zhou, Y.-G. Chem.
Commun. 2014, 50, 9588.
(7) (a) Rueping, M.; Antonchick, A. R.; Theissmann, T. Angew.
Chem., Int. Ed. 2006, 45, 3683. (b) Rueping, M.; Dufour, J.; Schoepke,
F. R. Green Chem. 2011, 13, 1084. (c) Guo, Q.-S.; Du, D.-M.; Xu, J.
Angew. Chem., Int. Ed. 2008, 759.
(8) Ren, L.; Lei, T.; Ye, J. X.; Gong, L. Z. Angew. Chem., Int. Ed. 2012,
51, 771.
(9) Han, Z.-Y.; Xiao, H.; Chen, X.-H.; Gong, L.-Z. J. Am. Chem. Soc.
2009, 131, 9182.
(10) (a) Parmar, D.; Sugiono, E.; Raja, S.; Rueping, M. Chem. Rev.
2014, 114, 9047. (b) Akiyama, T.; Itoh, J.; Yokota, K.; Fuchibe, K.
Angew. Chem., Int. Ed. 2004, 43, 1566. (c) Terada, M.; Uraguchi, D. J.
Am. Chem. Soc. 2004, 126, 5356.
(11) Tu, X. F.; Gong, L. Z. Angew. Chem., Int. Ed. 2012, 51, 11346.
(12) (a) Raynal, M.; Ballester, P.; Vidal-Ferran, A.; van Leeuwen, P.
W. N. M. Chem. Soc. Rev. 2014, 43, 1660. (b) Mahlau, M.; List, B.
Angew. Chem., Int. Ed. 2013, 52, 518. (c) Brak, K.; Jacobsen, E. N.
Angew. Chem., Int. Ed. 2013, 52, 534. (d) Phipps, R. J.; Hamilton, G.
L.; Toste, F. D. Nat. Chem. 2012, 4, 603. (e) Avila, E. P.; Amarante, G.
W. ChemCatChem 2012, 4, 1713.
(13) (a) Zi, W. W.; Wang, Y. M.; Toste, F. D. J. Am. Chem. Soc. 2014,
136, 12864. (b) Wang, P.-S.; Lin, H.-C.; Zhai, Y.-J.; Han, Z.-Y.; Gong,
L.-Z. Angew. Chem., Int. Ed. 2014, 53, 12218. (c) Terada, M.; Li, F.;
Toda, Y. Angew. Chem., Int. Ed. 2014, 53, 235. (d) Nelson, H. M.;
Reisberg, S. H.; Shunatona, H. P.; Patel, J. S.; Toste, F. D. Angew.
Chem., Int. Ed. 2014, 53, 5600. (e) Terada, M.; Yamanaka, T.; Toda, Y.
Chem.Eur. J. 2013, 19, 13658. (f) Chen, W. Y.; Hartwig, J. F. J. Am.
Chem. Soc. 2013, 135, 2068. (g) Auge, M.; Barbazanges, M.; Tran, A.

Note

T.; Simonneau, A.; Elley, P.; Amouri, H.; Aubert, C.; Fensterbank, L.;
Gandon, V.; Malacria, M.; Moussa, J.; Ollivier, C. Chem. Commun.
2013, 49, 7833. (h) Mourad, A. K.; Leutzow, J.; Czekelius, C. Angew.
Chem., Int. Ed. 2012, 51, 11149. (i) McInturff, E. L.; Yamaguchi, E.;
Krische, M. J. J. Am. Chem. Soc. 2012, 134, 20628. (j) Arthuis, M.;
Beaud, R.; Gandon, V.; Roulland, E. Angew. Chem., Int. Ed. 2012, 51,
10510. (k) Wang, C.; Han, Z. Y.; Luo, H. W.; Gong, L. Z. Org. Lett.
2010, 12, 2266. (l) Hamilton, G. L.; Kang, E. J.; Mba, M.; Toste, F. D.
Science 2007, 317, 496.
(14) (a) Müller, T. E.; Beller, M. Chem. Rev. 1998, 98, 675. (b) Li, Z.;
Brouwer, C.; He, C. Chem. Rev. 2008, 108, 3239. (c) Müller, T. E.;
Hultzsch, K. C.; Yus, M.; Foubelo, F.; Tada, M. Chem. Rev. 2008, 108,
3795. (d) Gorin, D. J.; Sherry, B. D.; Toste, F. D. Chem. Rev. 2008,
108, 3351. (e) Hashmi, A. S. K.; Rudolph, M. Chem. Soc. Rev. 2008, 37,
1766. (f) Marion, N.; Nolan, S. P. Chem. Soc. Rev. 2008, 37, 1776.
(g) Widenhoefer, R. A. Chem.Eur. J. 2008, 14, 5382. (h) Sengupta,
S.; Shi, X. ChemCatChem 2010, 2, 609. (i) Corma, A.; Leyva-Perez, A.;
Sabater, M. J. Chem. Rev. 2011, 111, 1657.
(15) (a) Wang, D.-S.; Zhou, J.; Wang, D.-W.; Guo, Y.-L.; Zhou, Y.-G.
Tetrahedron Lett. 2010, 51, 525. (b) Wang, Z.-J.; Deng, G.-J.; Li, Y.;
He, Y.-M.; Tang, W.-J.; Fan, Q.-H. Org. Lett. 2007, 9, 1243.

4759

DOI: 10.1021/acs.joc.5b00153
J. Org. Chem. 2015, 80, 4754−4759

